Bio-Techne Corp. (TECH)
Last updated: 2026-10-21 08:20:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Bio-Techne Corp. (TECH) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $72.58, with a market capitalization of $11.37B and a P/E ratio of 62.59. Over the past 52 weeks, its price has ranged from $43.20 to $72.69. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$11.37B | |
$72.48 | |
$135.96 | |
$7.67 | |
$72.49 | |
3.06M | |
3.03M | |
62.59 | |
$72.69 | |
$43.20 | |
0.44% | |
-- |
Bio-Techne Corp. (TECH) Pre-Market Stock Price
Bio-Techne Corp. (TECH) is trading at $70.76 in pre-market trading as of 2026-10-20 23:31:00, down 2.38% ($1.73) from the previous close of $72.49
Pre-market trading shows how investors are pricing TECH before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Bio-Techne Corp. (TECH) 7-Day Stock Price Change
Over the past seven days, Bio-Techne Corp. (TECH) moved from $72.56 to $72.58, representing a gain of 0.03% ($0.02).
The stock traded between $70.75 and $72.61 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 2.46 million shares, down versus the previous seven-day period, indicating lower trading activity.
TECH 52-Week Price Position
Position in Range: 99.6%
TECH is currently trading at $72.58, placing it 99.6% of the way from its 52-week low of $43.20 to its 52-week high of $72.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Bio-Techne Corp. (TECH)?
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Bio-Techne Corp. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 3000 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Bio-Techne Corp. (TECH) Stock on MEXC
Eligible investors can buy real shares of Bio-Techne Corp. (TECH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Bio-Techne Corp. (TECH) stock price today?
2.Is TECH stock going up or down today?
3.What is TECH pre-market price?
4.What is TECH after-hours price?
5.Is TECH stock trading now?
6.Where does TECH sit relative to its 52-week high and low?
7.What sector is Bio-Techne Corp. in?
8.What is Bio-Techne Corp.'s market capitalization and where is it listed?
9.How is TECH valued in terms of P/E ratio and EPS?
10.Does Bio-Techne Corp. pay a dividend?
Explore More US Stocks
Search Stocks
TECH Stock Calculator
Estimate the value between TECH shares and USD.
TECH Shares to USD
1.00 TECH shares = 72.58 USD
Calculations are estimates based on the latest available price and are for reference only.


